For questions or suggestions, you may contact us below
BSIM Therapeutics welcomes biotechnology and pharmaceutical development partners that share the goal of bringing new therapies to patients with TTR amyloidoses worldwide.
Our commitment towards the development of novel and safe drugs for unmet needs in TTR amyloidoses walks hand in hand with appealing investment opportunities. We want to leave our mark in this challenging field and invite prospective investors to make part of it.
Working With Us
We are always looking for talented, enthusiastic and highly motivated individuals with demonstrated expertise in drug discovery and development to collaborate with us.